Neublastin

N/A

Report date: 2024/12/31 17:39:43

Base Information

Drug NameNeublastin
Drug Alias NameEnovinARTNARGENT NeublastinArteminBG-00010
ClassificationBiologics
Mechanisms of ActionLow affinity neurotrophin receptor p75NTR antagonists
TargetsLow affinity neurotrophin receptor p75NTR
Therapy Area/IndicationsRadiculopathySciatica
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlandsAustralia
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNsgene As
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiogen Inc
Active IndicationsN/A
Inactive IndicationsRadiculopathySciatica

Other Information

ATC CodeN/A
Related LinksN/A